zimislecel-enables-insulin-independence-in-10-participants-with-type-1-diabetes

"Stem cell therapy is showing tremendous promise in transforming type 1 diabetes care, offering real hope for insulin independence,” Marlon Pragnell, the ADA’s vice president of research and science., said in a statement.3 "With advances in genetic engineering, these therapies may one day also evade immune attack—eliminating the need for immunosuppressive drugs."